Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.12.2023 | Case report

Eculizumab/Meningococcal-vaccine-groups-A-C-Y-W-135-conjugate

Various toxicities and lack of efficacy

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Nishimura JI, et al. Real-world safety profile of eculizumab in patients with paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, or generalized myasthenia gravis: an integrated analysis of post-marketing surveillance in Japan. International Journal of Hematology 118: 419-431, Jan 2023. Available from: URL: https://dx.doi.org/10.1007/s12185-023-03630-x Nishimura JI, et al. Real-world safety profile of eculizumab in patients with paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, or generalized myasthenia gravis: an integrated analysis of post-marketing surveillance in Japan. International Journal of Hematology 118: 419-431, Jan 2023. Available from: URL: https://​dx.​doi.​org/​10.​1007/​s12185-023-03630-x
Metadaten
Titel
Eculizumab/Meningococcal-vaccine-groups-A-C-Y-W-135-conjugate
Various toxicities and lack of efficacy
Publikationsdatum
01.12.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-51842-8

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Multiple drugs

Case report

Prednisolone

Case report

Vincristine

Case report

Amiodarone